SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
SBFM - Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.